Kovitz Investment Group Partners’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,780
Closed -$327K 414
2022
Q2
$327K Sell
15,780
-1,355,254
-99% -$24.1M 0.01% 360
2022
Q1
$23M Buy
1,371,034
+423,994
+45% +$7.41M 0.44% 41
2021
Q4
$25.6M Sell
947,040
-294,625
-24% -$5.55M 0.6% 38
2021
Q3
$22.5M Buy
1,241,665
+254,522
+26% +$5.84M 0.45% 39
2021
Q2
$26.7M Buy
987,143
+140,907
+17% +$3.94M 0.52% 39
2021
Q1
$25.4M Sell
846,236
-52,074
-6% -$1.78M 0.59% 38
2020
Q4
$25.8M Sell
898,310
-588,237
-40% -$15.9M 0.63% 38
2020
Q3
$36.3M Sell
1,486,547
-64,719
-4% -$1.4M 1.02% 34
2020
Q2
$27.8M Sell
1,551,266
-348,134
-18% -$4.58M 0.86% 37
2020
Q1
$15.5M Sell
1,899,400
-470,678
-20% -$5.38M 0.56% 41
2019
Q4
$31.3M Sell
2,370,078
-101,570
-4% -$1.23M 0.91% 33
2019
Q3
$29.4M Buy
+2,471,648
New +$45.8M 0.94% 31

Other funds holding CVET

Kovitz Investment Group Partners's CVET Position: Q3 2022 in Review

Kovitz Investment Group Partners sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 15,780 shares — an estimated $327K sold.

Kovitz Investment Group Partners first reported a position in CVET in Q3 2019 and held it in 12 quarters. The position peaked at $36.3M in Q3 2020. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Kovitz Investment Group Partners reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 15,780 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $327K.
  • Kovitz Investment Group Partners first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
  • Kovitz Investment Group Partners's Covetrus, Inc. Common Stock position peaked at $36.3M in Q3 2020.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Kovitz Investment Group Partners's 13F filing for Q3 2022, filed 9 Nov 2022.